About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-ATP6&8
T8993C
T8993C-F4
T8993C-F5
T8993C-F6
T8993C-F7
T8993C-F8
T8993C-F9
T8993G
T8993G-F41
T8993G-F1
T8993G-F2
T8993G-F3
T8993G-F4
T8993G-F5
T8993G-F6
T8993G-F7
T8993G-F8
T8993G-F10
T8993G-F12
T8993G-F14
T8993G-F15
T8993G-F23
T8993G-F26
T8993G-F28
T8993G-F29
T8993G-F32
T8993G-F33
T8993G-F34
T8993G-F30
T8993G-F31
T8993G-F35
T8993G-F36
T8993G-F43
T8993G-F44
T8993G-F45
T8993G-F42
T8993G-F46
T8993G-F48
T8993G-F49
T8993G-F50
T8993G-F47
T8993G-F53
T8993G-F54
T8993G-F55
T8993G-F58
A8795G
A8812G
A8836G
A8890G
A8938G
A9016G
A9016G-F1
A9041G
A9058G
A9058G-F1
A9115G
A9115G-F2
A9155G
A9155T
C8578T
C8578T-F1
C8608T
C8611A
C8932T
C8932T-F2
C9154T
G8573A
G8573A-F1
G8723T
G8782A
G8839C
G8839C-F1
G8921A
G8959A
G8969A
G8969A-F5
G8969A-F3
G8989C
G9026A
G9026A-F2
G9133A
G9133A-F1
G9139A
T8597C
T8612C
T8668C
T8672C
T8741G
T8777C
T8797C
T8821G
T8843C
T8851C
T8851C-F1
T8881C
T8909C
T8936A
T8936A-F1
T8951C
T8999C
T9017C
T9017C-F1
T9032C
T9032C-F1
T9035C
T9035C-F2
T9035C-F1
T9088C
T9088C-F1
T9098C
T9101C
T9101C-F2
T9152C
T9152C-F1
T9166C
T9176C
T9176C-F2
T9176C-F3
T9176C-F16
T9176C-F15
T9176C-F14
T9176C-F5
T9176C-F4
T9176G
T9176G-F1
T9176G-F2
T9185C
T9185C-F2
T9185C-F3
T9185C-F4
T9185C-F5
T9185C-F6
T9185C-F7
T9185C-F8
T9185C-F11
T9185C-F13
T9185C-F15
T9185C-F16
T9185C-F17
T9185C-F25
T9185C-F26
T9185C-F28
T9185C-F32
T9185C-F33
A8381G
A8411G
A8411G-F1
A8527G
A8527G-F2
C8382T
C8393T
C8393T-F1
C8481T
C8558T
C8561G
C8561G-F1
C8561T
C8561T-F1
G8529A
G8572A
G8572A-F1
T8403C
T8418C
T8424C
T8490C
T8528C
T8528C-F1
T8528C-F4
T8528C-F5
T8528C-F8
T8570C
Edit by Mitofam Team
-
+
首页
T9035C
# **General Information** | **Position** | **9035** | **Variant** | **m.9035T\>C** | **Locus** | **MT\-ATP6** | **Amino\-AcidChange** | **L170P** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \+ | **Heteroplasmy** | \+ | **APOGEE2** | Pathogenic | **Pathogenicity** | Cfrm \[LP] | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.9035T\>C** variant in MT\-ATP6 has been reported in 5 pedigrees. To date, 13 carriers have been reported. Homoplasmy was reported in 2/13 carriers (15\.4%), and 8/13 carriers (61\.5%) were affected. The main clinical manifestations among affected carriers included ataxia, complex HSP with asymmetric, late\-onset pure HSP, leg cramps after exercise, mental deficit, severe motor and speech delay, short stature and speech delay., sub\-acute ophthalmoplegia and ataxia with long tract signs, and other features. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 9035 | m.9035T\>C | [T9035C\-F2 ](https://mitofam.com/doc/1794/)| Belgium | severe motor/speech delay, spastic ataxia, epilepsy | 1 | 1 | 2022 | [35159298](https://pubmed.ncbi.nlm.nih.gov/35159298/) | | | 2 | 9035 | m.9035T\>C | T9035C\-F4 | Chile | Late\-onset hereditary spastic paraplegia | 2 | 1 | 2025 | [41222985](https://pubmed.ncbi.nlm.nih.gov/41222985/) | | | 3 | 9035 | m.9035T\>C | T9035C\-F5 | Belgium | ataxia, ophthalmoplegia, diplopia, visual loss, urinary retention, nystagmus | 0 | 0 | 2022 | [35159298](https://pubmed.ncbi.nlm.nih.gov/35159298/) | | | 4 | 9035 | m.9035T\>C | [T9035C\-F1](https://mitofam.com/doc/1793/) | UK | Adult\-onset spinocerebellar syndrome | 3 | 3 | 2012 | [22577227](https://pubmed.ncbi.nlm.nih.gov/22577227/) | Family B | | 5 | 9035 | m.9035T\>C | T9035C\-F6 | France | Mental deficit; cerebellar syndrome; pyramidal syndrome; episodic paralysis; axonal sensory\-motor peripheral neuropathy. | 0 | 0 | 2020 | [32858252](https://pubmed.ncbi.nlm.nih.gov/32858252/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 9035 | m.9035T\>C | T9035C\-F2 | T9035C\-F2\-II1 | Fam | M | Y | Y | A | 2 | Homo | / | / | Homo(F) | Severe motor and speech delay; spastic ataxia; hypotonia; brisk reflexes; extensor plantar responses | | | 2 | 9035 | m.9035T\>C | T9035C\-F2 | T9035C\-F2\-I2 | Uninf | F | N | N | A | ND | 31% | / | / | / | Healthy | | | 3 | 9035 | m.9035T\>C | T9035C\-F5 | T9035C\-F5\-P1 | Uninf | F | Y | Y | A | 19 | Homo | Homo | / | Homo(F) | Ataxia; ophthalmoplegia; ptosis; nystagmus; urinary retention; no cognitive impairment | | | 4 | 9035 | m.9035T\>C | T9035C\-F4 | T9035C\-F4\-P1 | Uninf | F | Y | Y | A | 67 | 83\.6% | / | / | / | Late\-onset pure HSP; lower extremity weakness and spasticity | | | 5 | 9035 | m.9035T\>C | T9035C\-F4 | T9035C\-F4\-P2 | Uninf | F | N | N | A | 46 | 90\.0% | / | / | / | Clinically unaffected carrier | | | 6 | 9035 | m.9035T\>C | T9035C\-F4 | T9035C\-F4\-P3 | Uninf | F | N | Y | A | 39 | 99\.7% | / | / | / | Complex HSP with asymmetric/multifocal sensorimotor axonal polyneuropathy | | | 7 | 9035 | m.9035T\>C | T9035C\-F1 | T9035C\-F1\-I2 | Fam | F | N | Y | A | 45 | 96% | / | / | / | Sub\-acute ophthalmoplegia and ataxia with long tract signs; residual midline ataxia; disordered eye movements; dysarthria. | | | 8 | 9035 | m.9035T\>C | T9035C\-F1 | T9035C\-F1\-I3 | Fam | F | N | Y | A | 43 | 90% | 96% | / | / | Leg cramps after exercise; gait ataxia; cerebellar dysarthria; pyramidal weakness; brisk reflexes. | | | 9 | 9035 | m.9035T\>C | T9035C\-F1 | T9035C\-F1\-II1 | Fam | F | N | Y | A | 4 | 95% | / | / | / | Short stature and speech delay. | | | 10 | 9035 | m.9035T\>C | T9035C\-F1 | T9035C\-F1\-II2 | Fam | F | N | N | A | ND | / | / | / | / | Healthy. | | | 11 | 9035 | m.9035T\>C | T9035C\-F1 | T9035C\-F1\-II3 | Fam | F | N | N | A | 11 | / | / | / | / | Healthy. | | | 12 | 9035 | m.9035T\>C | T9035C\-F1 | T9035C\-F1\-II4 | Fam | F | N | N | A | 8 | / | / | / | / | Healthy. | | | 13 | 9035 | m.9035T\>C | T9035C\-F6 | T9035C\-F6\-P1 | Uninf | ND | Y | Y | A | 31 | / | 100% | / | 100%(F) | Mental deficit; cerebellar syndrome; pyramidal syndrome; episodic paralysis; axonal sensory\-motor peripheral neuropathy. | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月30日 14:43
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)